Application of the diagnostic criteria for Common Variable Immunodeficiency in resource-limited settings

Main Article Content

Jesús A. Álvarez-Álvarez
Alejandro Gallon Duque
Estefanía Vásquez-Echeverri
Isaura P. Sánchez
Sebastián Gutierrez Hincapié
Rubén D. Gómez-Arias
Julio C. Orrego Arango
José L. Franco
Claudia M. Trujillo-Vargas


Common variable immunodeficiency, CVID diagnosis, ESID registry working definitions, inborn errors of immunity, primary immuno-deficiency diseases


Introduction: Common variable immunodeficiency (CVID) is the most prevalent symptomatic humoral deficiency; however, its heterogeneous presentation makes the diagnosis difficult. The present study is aimed to verify the CVID diagnostic criteria as established by the European Society for Immunodeficiencies in 42 CVID patients from our outpatient clinic.

Methods: Information was collected from their medical records and when needed, lymphocyte subpopulations in peripheral blood (PB) were performed by flow cytometry.

Results: All the patients fulfilled the clinical working definition for CVID and showed decreased serum IgG and IgA at diagnosis. Over two-thirds of the patients had decreased memory B cell percentages. However, the remaining patients exhibited other quantitative B cell defects in PB. Evaluation of vaccination responses was only found in 13 records and 69% were not responsive. None of the patients were subjected to vaccination studies to both, T-cell dependent and independent antigens. The two required tests to evaluate T cell responses were performed in 84.2% of the patients and reported normal. Without the support of third-party payers, only 34.2% of our patients would have completed the required evaluations.

Conclusions: Further efforts are needed to speed up CVID diagnosis in low-resourced settings, increasing the availability of the required resources and optimizing the healthcare supply chain.

Abstract 257 | PDF Downloads 166 HTML Downloads 43 XML Downloads 6


1. Franco-Gallego A, Trujillo CM, Rojas JL, Correa N, Franco JL. Deficiencia selectiva de inmunoglobulina A: manifestaciones clínicas, hallazgos de laboratorio y diagnóstico preciso. Rev CES Med. 2020;34(1):64–73. 10.21615/cesmedicina.34.1.6

2. Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020;40(1): 66–81. 10.1007/s10875-020-00758-x

3. Yong PF, Thaventhiran JE, Grimbacher B. “A rose is a rose is a rose, ” but CVID is Not CVID common variable immune deficiency (CVID), what do we know in 2011? Adv Immunol. 2011;111:47–107. 10.1016/B978-0-12-385991-4.00002-7

4. Odnoletkova I, Kindle G, Quinti I, Grimbacher B, Knerr V, Gathmann B, et al. The burden of common variable immunodeficiency disorders: A retrospective analysis of the European Society for Immunodeficiency (ESID) registry data. Orphanet J Rare Dis. 2018;13(1):201. 10.1186/s13023-018-0941-0

5. Ho HE, Cunningham-Rundles C. Non-infectious complications of common variable immunodeficiency: Updated clinical spectrum, sequelae, and insights to pathogenesis. Front Immunol. 2020;11:149. 10.3389/fimmu.2020.00149

6. Abolhassani H, Aghamohammadi A, Abolhassani F, Eftekhar H, Heidarnia M, Rezaei N. Health policy for common variable immunodeficiency: Burden of the disease. J Investig Allergol Clin Immunol. 2011;21(6):454–458. PMid: 21995178.

7. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: Division into distinct clinical phenotypes. Blood. 2008;112(2):277–286. 10.1182/blood-2007-11-124545

8. Jolles S. The variable in common variable immunodeficiency: A disease of complex phenotypes. J Allergy Clin Immunol Pract. 2013;1(6):545–556. 10.1016/j.jaip.2013.09.015

9. Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immuno-deficiencies (ESID) Registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7(6):1763–1770. 10.1016/j.jaip.2019.02.004

10. Ameratunga R, Brewerton M, Slade C, Jordan A, Gillis D, Steele R, et al. Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front Immunol. 2014;5:415. 10.3389/fimmu.2014.00415

11. Ameratunga R, Woon ST. Perspective: Evolving concepts in the diagnosis and understanding of common variable immunodeficiency disorders (CVID). Clin Rev Allergy Immunol. 2020;59(1):109–121. 10.1007/s12016-019-08765-6

12. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93(3): 190–197. 10.1006/clim.1999.4799

13. Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. International Consensus Document (ICON): Common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38–59. 10.1016/j.jaip.2015.07.025

14. Webster PC. Health in Colombia: A system in crisis. CMAJ. 2012;184(6):E289–E290. 10.1503/cmaj.109-4124

15. Vargas I, Mogollón-Pérez AS, De Paepe P, Ferreira da Silva MR, Unger JP, Vázquez ML. Barriers to healthcare coordination in market-based and decentralized public health systems: A qualitative study in healthcare networks of Colombia and Brazil. Health Policy Plan. 2016;31(6):736–748. 10.1093/heapol/czv126

16. De La Torre Sanclemente A, Molina RG, Valencia YV. Knowledge management: Generating value in healthcare. J Med Syst. 2019;43(12):330. 10.1007/s10916-019-1454-7

17. Meyts I, Bousfiha A, Duff C, Singh S, Lau YL, Condino-Neto A, et al. Primary immunodeficiencies: A decade of progress and a promising future. Front Immunol. 2020;11:625–753. 10.3389/fimmu.2020.625753

18. Erjaee A, Bagherpour M, Van Rooyen C, Van den Berg S, Kinnear CJ, Green RJ, et al. Primary immunodeficiency in Africa–A review. S Afr Med J. 2019;109(8b):3–11. 10.7196/SAMJ.2019.v109i8b.13820

19. Dauyey Z, Poddighe D. Diagnostic barriers in children with immunodeficiencies in Central Asia: A case-based discussion. Pediatr Rep. 2021;13(3):483–489. 10.3390/pediatric13030055

20. Erazo-Borrás LV, Álvarez-Álvarez JA, Perez-Romero CA, Orrego-Arango JC, Franco-Restrepo JL, Trujillo-Vargas CM. Skewed invariant natural killer T (iNKT) cells, impaired iNKT:B cell help and decreased SAP expression in blood lymphocytes from patients with common variable immunodeficiency. Scand J Immunol. 2017;86(3):171–178. 10.1111/sji.12576

21. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: Defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77–85. 10.1182/blood-2007-06-091744

22. Driessen GJ, van Zelm MC, van Hagen PM, Hartwig NG, Trip M, Warris A, et al. B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency. Blood. 2011;118(26): 6814–6823. 10.1182/blood-2011-06-361881

23. Ameratunga R, Storey P, Barker R, Jordan A, Koopmans W, Woon ST. Application of diagnostic and treatment criteria for common variable immunodeficiency disorder. Expert Rev Clin Immunol. 2016;12(3):257–266. 10.1586/1744666X.2016.1126509

24. Ameratunga R, Longhurst H, Steele R, Woon ST. Comparison of diagnostic criteria for common variable immunodeficiency disorders (CVID) in the New Zealand CVID cohort study. Clin Rev Allergy Immunol. 2021;61(2):236–244. 10.1007/s12016-021-08860-7

25. Körber N, Pohl L, Weinberger B, Grubeck-Loebenstein B, Wawer A, Knolle PA, et al. Hepatitis B vaccine non-responders show higher frequencies of CD24high Cd38high regulatory B cells and lower levels of IL-10 expression compared to responder. Front Immunol. 2021;12:713351. 10.3389/fimmu.2021.713351

26. Baloh C, Reddy A, Henson M, Prince K, Buckley R, Lugar P. 30-Year review of pediatric-and adult-onset CVID: Clinical correlates and prognostic indicators. J Clin Immunol. 2019;39(7):678–687. 10.1007/s10875-019-00674-9

27. von Spee-Mayer C, Koemm V, Wehr C, Goldacker S, Kindle G, Bulashevska A, et al. Evaluating laboratory criteria for combined immunodeficiency in adult patients diagnosed with common variable immunodeficiency. Clin Immunol. 2019;203: 59–62. 10.1016/j.clim.2019.04.001

28. Bateman EA, Ayers L, Sadler R, Lucas M, Roberts C, Woods A, et al. T cell phenotypes in patients with common variable immunodeficiency disorders: Associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol. 2012;170(2):202–211. 10.1111/j.1365-2249.2012.04643.x

29. Westh L, Mogensen TH, Dalgaard LS, Bernth Jensen JM, Katzenstein T, Hansen AE, et al. Identification and characterization of a nationwide danish adult common variable immunodeficiency cohort. Scand J Immunol. 2017;85(6):450–461. 10.1111/sji.12551